drugset / Trial / NCT02191384
Comparison of Orcinoside With Placebo in Treatment of MDD
Phase 2
Completed
186 enrolled
Shanghai Mental Health Center
Kun Ming KingBio Biotechnology Co. LTD · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether Orcinoside Capsule in different doses are effective in the treatment of Depression. And to explore the preliminary information of safety and efficacy of Orcinoside Capsule in the Chinese Patients with Depression.
Timeline
- Start
- 2014-07
- Primary completion
- 2016-03-09
- Completion
- 2016-03-09
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Orcinoside | Unknown | 25 mg | Oral |
| Subject | Orcinoside | Unknown | 50 mg | Oral |
| Subject | Orcinoside | Unknown | 100 mg | Oral |
| Subject | Orcinoside | Unknown | 200 mg | Oral |
| Subject | Orcinoside | Unknown | 400 mg | Oral |
| Subject | Orcinoside | Unknown | 600 mg | Oral |